BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity.
D000284:Administration, Oral; D000818:Animals; D000935:Antifungal Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D003883:Arthrodermataceae / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D005658:Fungi / Q000187:drug effects; D007093:Imidazoles / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice
D000935:Antifungal Agents; D007093:Imidazoles